Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q2902977> ?p ?o }
Showing triples 1 to 43 of
43
with 100 triples per page.
- Q2902977 subject Q6442932.
- Q2902977 subject Q7215865.
- Q2902977 subject Q7334131.
- Q2902977 subject Q8297705.
- Q2902977 subject Q8503308.
- Q2902977 abstract "Bilastine (trade name Bilaxten) is a second generation antihistamine drug for the treatment of allergic rhinoconjunctivitis and urticaria (hives).It exerts its effect as a selective histamine H1 receptor antagonist, and has a effectiveness similar to cetirizine, fexofenadine and desloratadine. It was developed in Spain by FAES Farma.Bilastine is approved in the European Union for the symptomatic treatment of allergic rhinoconjunctivitis and urticaria, but it is not approved by the U.S. Food and Drug Administration for any use in the United States. Bilastine meets the current European Academy of Allergy and Clinical Immunology (EAACI) and Allergic Rhinitis and its Impact of Asthma (ARIA) criteria for medication used in the treatment of allergic rhinitis.Bilastine has been effective in the treatment of ocular symptoms and diseases of allergies, including rhinoconjuctivitis. Additionally, bilastine has been shown to improve quality of life, and all nasal and ocular symptoms related to allergic rhinitis.".
- Q2902977 iupacName "2-[4-(2-{4-[1-(2-Ethoxyethyl)-1H-benzimidazol-2-yl]-1-piperidinyl}ethyl)phenyl]-2-methylpropanoic acid".
- Q2902977 thumbnail Bilastine.svg?width=300.
- Q2902977 wikiPageWikiLink Q1328275.
- Q2902977 wikiPageWikiLink Q14877161.
- Q2902977 wikiPageWikiLink Q187440.
- Q2902977 wikiPageWikiLink Q204711.
- Q2902977 wikiPageWikiLink Q272436.
- Q2902977 wikiPageWikiLink Q29.
- Q2902977 wikiPageWikiLink Q324089.
- Q2902977 wikiPageWikiLink Q407595.
- Q2902977 wikiPageWikiLink Q410943.
- Q2902977 wikiPageWikiLink Q413486.
- Q2902977 wikiPageWikiLink Q415122.
- Q2902977 wikiPageWikiLink Q418060.
- Q2902977 wikiPageWikiLink Q423075.
- Q2902977 wikiPageWikiLink Q423437.
- Q2902977 wikiPageWikiLink Q42982.
- Q2902977 wikiPageWikiLink Q471521.
- Q2902977 wikiPageWikiLink Q483261.
- Q2902977 wikiPageWikiLink Q494483.
- Q2902977 wikiPageWikiLink Q5412205.
- Q2902977 wikiPageWikiLink Q6442932.
- Q2902977 wikiPageWikiLink Q7215865.
- Q2902977 wikiPageWikiLink Q7218.
- Q2902977 wikiPageWikiLink Q7334131.
- Q2902977 wikiPageWikiLink Q79785.
- Q2902977 wikiPageWikiLink Q8297705.
- Q2902977 wikiPageWikiLink Q8503308.
- Q2902977 iupacname "2".
- Q2902977 type ChemicalCompound.
- Q2902977 type ChemicalSubstance.
- Q2902977 type ChemicalObject.
- Q2902977 type Thing.
- Q2902977 type Q11173.
- Q2902977 comment "Bilastine (trade name Bilaxten) is a second generation antihistamine drug for the treatment of allergic rhinoconjunctivitis and urticaria (hives).It exerts its effect as a selective histamine H1 receptor antagonist, and has a effectiveness similar to cetirizine, fexofenadine and desloratadine. It was developed in Spain by FAES Farma.Bilastine is approved in the European Union for the symptomatic treatment of allergic rhinoconjunctivitis and urticaria, but it is not approved by the U.S.".
- Q2902977 label "Bilastine".
- Q2902977 depiction Bilastine.svg.